Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

- PMLiVE

AstraZeneca expands antisense alliance with Isis

Builds on existing deal that sees the firm develop new medicines for a host of diseases

- PMLiVE

Critical thinking

Assessing the Darwinian model of mutation in pharmaceutical companies

Pharma deals in July 2015

A hot summer month for industry M&A, finds Medius Deal Watch

Merck & Co expands board and adds new directors

Appoints Dr Paul Rothman and Pamela Craig

Roche's Perjeta pertuzumab

European approval for Roche’s next-gen breast cancer drug

Perjeta now available in EU for use before surgery in early stage aggressive breast cancer

- PMLiVE

Humira gains EU licence first for Hidradenitis Suppurativa

Thirteenth licence for the drug in Europe

ABPI Scotland appoints Sandra Auld as director

Takes over from Andrew-Powrie Smith who left to join EPFIA this year

Bristol-Myers Squibb (BMS) building

BMS signs Opdivo combination pact with Kyowa Hakko Kirin 

Rounds off a week of deals in the immunotherapy space for big pharma

- PMLiVE

Hints of recovery at GSK as group sales climb

Drug revenue still falling but vaccines and HIV drugs help offset Advair decline

Lilly brings Glucagon app to Android devices

Follows app's 2012 debut in iPhone version

Boehringer Ingelheim headquarters

Hikma pays $2.6bn for Boehringer’s US generics unit

Follows Teva’s $40.5bn purchase of Allgeran’s generics business earlier this week

- PMLiVE

Access to new hep C treatments put under the spotlight

NICE plans to restrict use of BMS’ Daklinza follow funding delay for Gilead's Sovaldi

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links